Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector
- PMID: 17235319
- DOI: 10.1038/sj.mt.6300024
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector
Abstract
Recent studies have indicated that type I interferon (IFN) enhances antibody responses and promotes isotype switching. In this study, we analyzed the role of type I IFN signaling during the generation of transgene product-specific antibody responses elicited by recombinant adenovirus (Ad) vectors. A vector derived from a human Ad serotype (AdHu5) induced low levels of type I IFN following infection of dendritic cells (DCs) and stimulated normal transgene product-specific antibody responses in mice that have a defective type I IFN receptor (IFNAR(-/-)). A vector derived from a chimpanzee Ad serotype (AdC68) induced very high levels of type I IFN following infection of DCs, and surprisingly, primed stronger transgene product-specific antibody responses in IFNAR(-/-) mice compared to wild-type mice. The increased antibody response in IFNAR(-/-) mice vaccinated with the AdC68 vector was mainly due to the generation of IgG1 antibodies that were not elicited in wild-type mice. The induction of IgG1 antibodies correlated with an increase in transgene product expression in IFNAR(-/-) mice and was not associated with an increase in T helper 2 responses. We conclude that type I IFN, when induced at high levels, can downregulate transgene product expression of Ad vectors and inhibit the formation of optimal antibody responses.
Similar articles
-
Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.J Immunol. 2005 Nov 1;175(9):6032-41. doi: 10.4049/jimmunol.175.9.6032. J Immunol. 2005. PMID: 16237098
-
A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.Mol Ther. 2007 Mar;15(3):608-17. doi: 10.1038/sj.mt.6300078. Epub 2007 Jan 16. Mol Ther. 2007. PMID: 17228314
-
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.J Virol. 2007 Jun;81(12):6594-604. doi: 10.1128/JVI.02497-06. Epub 2007 Apr 11. J Virol. 2007. PMID: 17428852 Free PMC article.
-
Type I interferon receptors: biochemistry and biological functions.J Biol Chem. 2007 Jul 13;282(28):20053-7. doi: 10.1074/jbc.R700006200. Epub 2007 May 14. J Biol Chem. 2007. PMID: 17502368 Review. No abstract available.
-
Interfer'n with antibody responses.Sci Immunol. 2016 Oct 21;1(4):eaaj1836. doi: 10.1126/sciimmunol.aaj1836. Sci Immunol. 2016. PMID: 28783688 Review.
Cited by
-
Codon Usage and Adenovirus Fitness: Implications for Vaccine Development.Front Microbiol. 2021 Feb 10;12:633946. doi: 10.3389/fmicb.2021.633946. eCollection 2021. Front Microbiol. 2021. PMID: 33643266 Free PMC article. Review.
-
Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response.Cell Host Microbe. 2016 May 11;19(5):713-9. doi: 10.1016/j.chom.2016.04.003. Epub 2016 Apr 20. Cell Host Microbe. 2016. PMID: 27107939 Free PMC article.
-
Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo.Blood. 2010 Sep 9;116(10):1669-77. doi: 10.1182/blood-2010-03-276949. Epub 2010 May 28. Blood. 2010. PMID: 20511542 Free PMC article.
-
Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice.Mol Ther Methods Clin Dev. 2019 Dec 24;16:108-125. doi: 10.1016/j.omtm.2019.12.003. eCollection 2020 Mar 13. Mol Ther Methods Clin Dev. 2019. PMID: 31934599 Free PMC article.
-
Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors.Gene Ther. 2008 Dec;15(24):1606-17. doi: 10.1038/gt.2008.114. Epub 2008 Jul 10. Gene Ther. 2008. PMID: 18615115 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources